Effettuare il login Iscriviti gratis

Akari Therapeutics Plc Margine di operatività

Cos'è Margine di operatività di Akari Therapeutics Plc?

Margine di operatività di Akari Therapeutics Plc è 0.00%

Qual è la definizione di Margine di operatività?



Il margine operativo è il rapporto tra il reddito operativo diviso per le vendite nette e presentato in percentuale.

Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.

Margine di operatività di aziende nel Health Care settore su NASDAQ rispetto a Akari Therapeutics Plc

Cosa fa Akari Therapeutics Plc?

akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.

Aziende con margine di operatività simili a Akari Therapeutics Plc